• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素的免疫调节和治疗活性。

Immunomodulatory and therapeutic activity of curcumin.

机构信息

Department of Otolaryngology, Hillman Cancer Centre, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.

出版信息

Int Immunopharmacol. 2011 Mar;11(3):331-41. doi: 10.1016/j.intimp.2010.08.014. Epub 2010 Sep 8.

DOI:10.1016/j.intimp.2010.08.014
PMID:20828642
Abstract

Inflammation is a disease of vigorous uncontrolled activated immune responses. Overwhelming reports have suggested that the modulation of immune responses by curcumin plays a dominant role in the treatment of inflammation and metabolic diseases. Observations from both in-vitro and in-vivo studies have provided strong evidence towards the therapeutic potential of curcumin. These studies have also identified a plethora of biological targets and intricate mechanisms of action that characterize curcumin as a potent 'drug' for numerous ailments. During inflammation the functional influence of lymphocytes and the related cross-talk can be modulated by curcumin to achieve the desired immune status against diseases. This review describes the regulation of immune responses by curcumin and effectiveness of curcumin in treatment of diseases of diverse nature.

摘要

炎症是一种由过度活跃的免疫反应引起的疾病。大量报告表明,姜黄素对免疫反应的调节在炎症和代谢性疾病的治疗中起着主导作用。体外和体内研究的观察结果为姜黄素的治疗潜力提供了有力的证据。这些研究还确定了大量的生物靶点和复杂的作用机制,使姜黄素成为治疗多种疾病的有效“药物”。在炎症过程中,姜黄素可以调节淋巴细胞的功能影响和相关的串扰,以达到针对疾病的理想免疫状态。本综述描述了姜黄素对免疫反应的调节作用及其在治疗多种疾病中的有效性。

相似文献

1
Immunomodulatory and therapeutic activity of curcumin.姜黄素的免疫调节和治疗活性。
Int Immunopharmacol. 2011 Mar;11(3):331-41. doi: 10.1016/j.intimp.2010.08.014. Epub 2010 Sep 8.
2
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.姜黄素在慢性病中作用的药理学基础:一种具有现代靶点的古老香料。
Trends Pharmacol Sci. 2009 Feb;30(2):85-94. doi: 10.1016/j.tips.2008.11.002. Epub 2008 Dec 26.
3
Curcumin and obesity: evidence and mechanisms.姜黄素与肥胖:证据与机制。
Nutr Rev. 2010 Dec;68(12):729-38. doi: 10.1111/j.1753-4887.2010.00341.x.
4
Spicy approach to cancer treatment.治疗癌症的辛辣方法。
J Natl Cancer Inst. 2011 Dec 21;103(24):1817-8. doi: 10.1093/jnci/djr526. Epub 2011 Dec 8.
5
Curcumin in inflammatory diseases.姜黄素在炎症性疾病中的应用。
Biofactors. 2013 Jan-Feb;39(1):69-77. doi: 10.1002/biof.1066. Epub 2012 Dec 22.
6
[Effect of NF-kappaB activation inhibitor curcumin on the oogenesis and follicular cell death in immune ovarian failure in mice].[核因子κB激活抑制剂姜黄素对小鼠免疫性卵巢衰竭中卵子发生及卵泡细胞死亡的影响]
Fiziol Zh (1994). 2010;56(4):96-101.
7
Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation.姜黄素(二阿魏酰甲烷)对术后炎症患者抗炎特性的评估。
Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):651-4.
8
Clinical Inquiry. Does turmeric relieve inflammatory conditions?临床探究。姜黄能缓解炎症性疾病吗?
J Fam Pract. 2011 Mar;60(3):155-6.
9
Curcumin attenuates oxidative stress and inflammatory response in the early phase after partial hepatectomy with simultaneous intraabdominal infection in rats.姜黄素减轻大鼠部分肝切除术后合并腹腔感染早期的氧化应激和炎症反应。
J Surg Res. 2010 Mar;159(1):497-502. doi: 10.1016/j.jss.2008.12.006. Epub 2008 Dec 31.
10
Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages.新型姜黄素单羰基类似物的合成及其对 LPS 刺激的 RAW 264.7 巨噬细胞的抗炎活性评价。
Eur J Med Chem. 2010 Dec;45(12):5773-80. doi: 10.1016/j.ejmech.2010.09.037. Epub 2010 Oct 8.

引用本文的文献

1
Mercury Can Bond to α-Carbon of Curcumin Increasing Stability in Aqueous Medium and Demonstrated Selective Cytotoxicity against Acute Leukemia.汞可与姜黄素的α-碳结合,提高其在水性介质中的稳定性,并对急性白血病表现出选择性细胞毒性。
ACS Omega. 2025 Apr 24;10(17):17416-17434. doi: 10.1021/acsomega.4c10710. eCollection 2025 May 6.
2
Research trajectory and future trends in curcumin related to immunity: a bibliometric analysis of publications from last two decades.姜黄素与免疫相关的研究轨迹及未来趋势:过去二十年出版物的文献计量分析
Front Immunol. 2025 Mar 24;16:1559670. doi: 10.3389/fimmu.2025.1559670. eCollection 2025.
3
Biocompatible Poly(ε-Caprolactone) Nanocapsules Enhance the Bioavailability, Antibacterial, and Immunomodulatory Activities of Curcumin.
生物相容的聚己内酯纳米胶囊提高姜黄素的生物利用度、抗菌和免疫调节活性。
Int J Mol Sci. 2024 Oct 4;25(19):10692. doi: 10.3390/ijms251910692.
4
Inhibition of HIV-1 infection with curcumin conjugated PEG-citrate dendrimer; a new nano formulation.姜黄素偶联聚乙二醇-柠檬酸树枝状聚合物抑制 HIV-1 感染:一种新的纳米制剂。
BMC Complement Med Ther. 2024 Oct 2;24(1):350. doi: 10.1186/s12906-024-04634-8.
5
The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management.姜黄素的光明面:关于其在癌症治疗中潜在治疗作用的叙述性综述
Cancers (Basel). 2024 Jul 18;16(14):2580. doi: 10.3390/cancers16142580.
6
Evaluation of Immunohistochemical Biomarkers in Diabetic Wistar Rats with Periodontal Disease.糖尿病性牙周病Wistar大鼠免疫组化生物标志物的评估
J Pers Med. 2024 May 15;14(5):527. doi: 10.3390/jpm14050527.
7
Curcumin as a regulator of Th17 cells: Unveiling the mechanisms.姜黄素作为Th17细胞的调节剂:揭示其机制
Food Chem (Oxf). 2024 Mar 12;8:100198. doi: 10.1016/j.fochms.2024.100198. eCollection 2024 Jul 30.
8
Common foods for boosting human immunity: A review.增强人体免疫力的常见食物:综述
Food Sci Nutr. 2023 Aug 18;11(11):6761-6774. doi: 10.1002/fsn3.3628. eCollection 2023 Nov.
9
Immunomodulatory effect from ethanol extract and ethyl acetate fraction of Valeton and Zijp: Transient receptor vanilloid protein approach.瓦莱顿和紫叶的乙醇提取物及乙酸乙酯部位的免疫调节作用:瞬时受体香草酸蛋白研究方法
Heliyon. 2023 Apr 20;9(5):e15582. doi: 10.1016/j.heliyon.2023.e15582. eCollection 2023 May.
10
Assessment of commitment to healthy daily habits and diets, preventive measures, and beliefs about natural products utilization during COVID-19 pandemic in certain population in Egypt and Saudi Arabia.对埃及和沙特阿拉伯特定人群在新冠疫情期间健康日常习惯和饮食、预防措施以及天然产品使用观念的评估。
Pharm Pract (Granada). 2022 Jul-Sep;20(3):2700. doi: 10.18549/PharmPract.2022.3.2700. Epub 2022 Aug 5.